التفاصيل البيبلوغرافية
| العنوان: |
Preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) improves prognosis in locally advanced breast cancer patients: an update of the Southern Italy Cooperative Oncology Group (SICOG) randomised trial 9908. |
| المؤلفون: |
Frasci, G.1, D'Aiuto, G.1, Comella, P.2, D'Aiuto, M.1, Di Bonito, M.3, Ruffolo, P.1, Iodice, G.2, Petrillo, A.4, Lastoria, S.5, Oliviero, P.1, Capasso, I.1, Montella, M.6, Siani, C.7, Santangelo, M.8, Vizioli, L.9, Comella, G.1 |
| المصدر: |
Annals of Oncology. Apr2010, Vol. 21 Issue 4, p707-716. 10p. 1 Diagram, 4 Charts, 3 Graphs. |
| مصطلحات موضوعية: |
*CISPLATIN, *PACLITAXEL, *BREAST cancer, *ANTINEOPLASTIC agents, *CANCER patients |
| مستخلص: |
Background: The present article reports the updated survival outcome of the 200 patients enrolled in the Southern Italy Cooperative Oncology Group 9908 trial, which compared 12 weekly cycles of cisplatin–epirubicin–paclitaxel (PET) with 4 triweekly (once every 3 weeks) cycles of epirubicin–paclitaxel (ET) in patients with locally advanced breast cancer (LABC). [ABSTRACT FROM PUBLISHER] |
| قاعدة البيانات: |
Academic Search Index |
Full Text Finder